ArticleJACC. Advances2025

An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists.

Sourbha S Dani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.